tiprankstipranks
Trending News
More News >
Brookdale Senior Living (BKD)
NYSE:BKD

Brookdale Senior Living (BKD) AI Stock Analysis

Compare
242 Followers

Top Page

BKD

Brookdale Senior Living

(NYSE:BKD)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - 5.2)
Rating:58Neutral
Price Target:
$15.50
▲(2.51% Upside)
Action:ReiteratedDate:02/20/26
The score is held back primarily by weak financial health (ongoing losses, negative equity, and elevated leverage), partly offset by improving cash generation. Technicals are supportive with a strong trend and positive momentum, and the latest earnings call/guidance reinforced accelerating RevPAR and EBITDA growth expectations, but valuation remains challenged due to negative earnings.
Positive Factors
Occupancy recovery and RevPAR growth
Sustained occupancy above the ~80% inflection and multi-year RevPAR gains materially improve operating leverage for a senior housing operator. Higher utilization supports recurring fee revenue stability, better fixed-cost absorption, and durable margin expansion if occupancy and pricing trends persist.
Adjusted EBITDA expansion and multi-year guidance
Consistent double-digit adjusted EBITDA growth and credible multi-year targets indicate improving operational efficiency and pricing power. Durable EBITDA improvement is central to deleveraging plans and can generate internal funding for CapEx and portfolio optimization if management sustains execution.
Improving cash generation (positive operating & free cash flow)
Conversion to positive operating and free cash flow provides a reliable source to fund prioritized CapEx, service debt, and support dispositions. Durable cash generation reduces refinancing pressure, strengthens liquidity optionality, and underpins management's plan to reduce leverage over multiple years.
Negative Factors
Elevated leverage and weakened equity cushion
High leverage and negative equity constrain financial flexibility, increase refinancing and covenant risk, and limit capacity for opportunistic investments. Durable deleveraging will require sustained EBITDA growth and asset sales; failure raises insolvency or restructuring risk in adverse cycles.
Ongoing net losses and inconsistent profitability
Persistent net losses erode retained earnings and equity, complicating balance-sheet repair. Inconsistent TTM profitability undermines confidence that reported EBITDA gains will sustainably translate to GAAP profit, limiting long-term capital accumulation and hindering confidence in sustained cash conversion.
Material cohort of underperforming communities
A sizable subset of low‑occupancy assets requires dispositions or intensive remediation, which consumes management bandwidth and capital. These assets depress aggregate margins and cash flow until resolved, and successful remediation or sale execution is necessary for durable margin recovery and portfolio stabilization.

Brookdale Senior Living (BKD) vs. SPDR S&P 500 ETF (SPY)

Brookdale Senior Living Business Overview & Revenue Model

Company DescriptionBrookdale Senior Living Inc. owns, manages, and operates senior living communities in the United States. It operates in three segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRCs). The Independent Living segment owns or leases communities comprising independent and assisted living units in a single community that are primarily designed for middle to upper income seniors. The Assisted Living and Memory Care segment owns or leases communities consisting of freestanding multi-story communities and freestanding single-story communities, which offer housing and 24-hour assistance with activities of daily living for the Company's residents. This segment also operates memory care communities for residents with Alzheimer's and other dementias. The CCRCs segment owns or leases communities that provides various living arrangements, such as independent and assisted living, memory care, and skilled nursing; and services to accommodate various levels of physical ability and healthcare needs. It also manages communities on behalf of others. As of December 31, 2021, the company owned 347 communities, leased 299 communities, and managed 33 communities on behalf of others. Brookdale Senior Living Inc. was incorporated in 2005 and is headquartered in Brentwood, Tennessee.
How the Company Makes MoneyBrookdale Senior Living generates revenue primarily through the fees charged for its various senior living services. The company operates on a rental model where residents pay monthly fees that cover accommodations, amenities, and care services. Key revenue streams include independent living, assisted living, memory care, and skilled nursing facilities. Additionally, Brookdale may earn revenue from ancillary services such as rehabilitation and therapy. The company also benefits from partnerships with healthcare providers, insurance companies, and government programs, which can enhance its service offerings and patient referrals, contributing to its overall earnings.

Brookdale Senior Living Earnings Call Summary

Earnings Call Date:Feb 18, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 12, 2026
Earnings Call Sentiment Positive
The call presented multiple clear positives: RevPAR growth beat guidance, adjusted EBITDA grew strongly (+19% to $458M) and occupancy recovered above the pivotal 80% mark with sustained operational initiatives (new COO, regional structure, centralized pricing/CapEx). The company returned to positive adjusted free cash flow and is actively optimizing its portfolio with expected proceeds (~$200M) and continued CapEx investment focused on high-ROI projects. Key headwinds include a miss on free cash flow versus target, Q4 cash outflow tied to tax and working capital timing, revenue pressure from unit reductions, a meaningful cohort of under-70% occupancy communities that remain to be resolved, and elevated leverage (8.9x) that still poses near-term financial risk. Overall the positives — tangible operating momentum, strong EBITDA expansion, occupancy gains, strategic organizational changes and credible 2026 guidance — significantly outweigh the lowlights, while management acknowledges the remaining execution risks.
Q4-2025 Updates
Positive Updates
RevPAR Growth Exceeds Guidance
Full-year 2025 RevPAR grew 5.7%, finishing at the top end of initial guidance (4.75%–5.75%). Fourth-quarter same-community RevPAR increased 5% YoY; consolidated Q4 RevPAR rose ~7.1% (offsetting unit reductions). Company guides to 8%–9% RevPAR growth for 2026.
Strong Adjusted EBITDA Expansion
Adjusted EBITDA for 2025 increased 19% YoY to $458 million (fourth consecutive year of double-digit EBITDA growth). Fourth-quarter adjusted EBITDA was $106 million, up 7% YoY. 2026 adjusted EBITDA guidance is $502–$516 million (mid-teens growth from baseline).
Occupancy Recovery and Momentum
Consolidated weighted average occupancy for Q4 2025 was 82.5% (same-community 83.5%), a 310 basis-point improvement YoY and ~70 bps sequential improvement. End-of-quarter consolidated occupancy closed at 83.7% (84.3% same-community). Full-year consolidated weighted average occupancy was 80.9%.
Return to Positive Adjusted Free Cash Flow
Brookdale generated $23 million of adjusted free cash flow in 2025, its first positive adjusted free cash flow since 2020 (despite missing the $30–$50 million target due to timing issues).
Portfolio Optimization and Expected Proceeds
Completed lease terminations and dispositions in 2025 (exited 58 leased communities / 6,466 units). As of 12/31/2025 the consolidated portfolio was 548 communities (370 owned, 178 leased). Company expects to sell 29 owned communities in 2026 for approximately $200 million of proceeds, targeting a stabilized ongoing portfolio of ~517 communities.
CapEx Prioritization and Increased Investment
Nondevelopment CapEx for 2025 was $170.7 million. For 2026 company projects nondevelopment CapEx of $175–$195 million, with a strategic shift toward larger, ROI-focused projects ("first impressions") prioritized by a new centralized asset/capital decision function.
Leverage Improvement and 2028 Target
Adjusted annualized leverage improved to 8.9x at year-end 2025 from 9.9x at prior year-end. Management reiterated a plan to reduce leverage to under 6x by 2028, primarily through EBITDA expansion and continued portfolio optimization.
Operational Leadership & Organizational Changes
Hired a dedicated Chief Operating Officer (first in >10 years), implemented a six-region operating structure, and created a Senior VP of Strategic Operations to centralize pricing, labor management and CapEx decisioning to accelerate operational improvements.
Quality & Health Initiatives
Net Promoter Score (NPS) improved by 19 points since 2022. Brookdale Health Plus expanded into 58 additional communities in 2025 (now serving >180 communities), with reported benefits including fewer avoidable ER visits/hospitalizations and improved resident and associate satisfaction.
Negative Updates
Adjusted Free Cash Flow Shortfall and Q4 Cash Outflow
Full-year adjusted free cash flow was $23 million, below the $30–$50 million target. Q4 2025 adjusted free cash flow was an outflow of $23 million due to seasonality (real estate tax timing), working capital timing and refinancing-related prepayments.
Revenue Pressure from Unit Reductions
Fourth-quarter resident fees of $715 million declined ~4% YoY. Full-year resident fees rose just 2.4% to $3.0 billion (5.7% RevPAR growth offset by a 3.2% decline in total average available units due to dispositions and lease nonrenewals). Q4 experienced a 10.5% reduction in total average units versus prior year.
Persisting Underperforming Communities
Eighty communities remained below the 70% occupancy threshold in Q4; while progress reduced the share of consolidated communities under 70% from 23% to 15%, a meaningful subset still requires disposition or SWAT remediation (14 slated for sale in 2026, 21 working with SWAT teams).
Q4 Margin Dynamics and Slower Quarterly EBITDA Growth
Fourth-quarter same-community operating margin declined by ~30 basis points and Q4 adjusted EBITDA growth (+7% YoY) lagged full-year performance (+19% YoY), reflecting seasonality, higher days/labor in Q4 and ongoing portfolio transitions.
High Leverage Remains a Risk
Despite improvement to 8.9x leverage, leverage remains elevated. Management targets sub-6x by 2028, but achieving this depends on sustained mid-teens EBITDA growth and successful asset dispositions/refinancings.
Acuity & Mix Headwinds
Company reported a trend of lower resident acuity (lower care rates), which dampens RevPOR; while rate increases offset this, mix changes can constrain revenue per occupied room and require continued focus on pricing and care mix management.
Seasonality & Weather Impact
Severe winter storms in late January impacted move-ins and tour activity in impacted markets (e.g., Texas, Tennessee); management noted recovery in early February but acknowledged short-term disruption to Q1 cadence.
Company Guidance
Brookdale guided 2026 RevPAR growth of 8%–9% and adjusted EBITDA of $502–$516 million, reiterated mid‑teens adjusted EBITDA growth through 2028 and a plan to drive adjusted leverage below 6.0x by year‑end 2028 (adjusted leverage was 8.9x at year‑end 2025); management expects to operate roughly 517 consolidated communities after dispositions, to sell 29 owned communities in 2026 for about $200 million of proceeds, to invest $175–$195 million in nondevelopment CapEx, to incur roughly $180 million of cash facility operating lease payments and about $162 million of G&A (ex. stock‑based comp and transaction/legal/restructuring costs) in 2026, with the guidance premised on continued occupancy gains above the ~80% inflection point and a mix of pricing and move‑in strength.

Brookdale Senior Living Financial Statement Overview

Summary
Cash flow is improving (positive operating cash flow and TTM free cash flow turning positive), but overall fundamentals remain pressured by ongoing net losses and a high-risk balance sheet with negative equity and elevated leverage. Inconsistencies noted in TTM profitability metrics also reduce confidence in the apparent improvement.
Income Statement
38
Negative
Revenue has been growing steadily (about 4% in 2023 and 2024, accelerating to ~264% in TTM (Trailing-Twelve-Months)). Profitability is the key issue: net income remains negative across recent periods, with net margins around -6% to -9% (TTM ~-8%). On the positive side, operating profitability improved from losses in 2022 to positive EBIT/EBITDA in 2023–2024; however, the TTM profitability figures appear inconsistent (EBIT/EBITDA and margins are unusually high versus revenue), which reduces confidence in the quality of the trend despite the headline improvement.
Balance Sheet
22
Negative
Leverage is elevated and remains a major constraint. Total debt is still substantial (TTM ~$1.15B; prior annual years were materially higher at ~$4.7B–$5.7B), but the capital structure is weakened by negative equity in TTM (about -$44.8M), which drives an unfavorable debt-to-equity relationship and signals a thin (or impaired) equity cushion. Returns on equity are negative in recent years, consistent with ongoing net losses, and overall balance-sheet risk remains high despite the apparent reduction in debt versus prior annual periods.
Cash Flow
55
Neutral
Cash generation has improved meaningfully. Operating cash flow is positive in 2023 and 2024 and increases further in TTM (about $218M), and free cash flow turned positive in TTM (~$80M) after negative free cash flow in 2022–2024. The main weakness is that cash flow still does not fully offset earnings pressure: operating cash flow relative to net income is modest in TTM, reflecting that reported losses are not yet consistently translating into strong surplus cash generation.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue3.12B2.98B2.87B2.74B2.75B
Gross Profit645.02M807.43M744.71M513.94M488.58M
EBITDA347.65M420.80M369.29M319.92M425.07M
Net Income-262.69M-201.94M-189.01M-238.43M-99.29M
Balance Sheet
Total Assets5.95B6.34B5.57B5.94B6.41B
Cash, Cash Equivalents and Short-Term Investments279.12M328.80M307.73M447.53M529.42M
Total Debt6.66B5.65B4.73B4.89B5.23B
Total Liabilities6.00B6.12B5.17B5.35B5.71B
Stockholders Equity-44.75M212.47M403.66M582.61M697.40M
Cash Flow
Free Cash Flow-294.52M-35.07M-70.28M-193.64M-271.29M
Operating Cash Flow218.03M166.18M162.92M3.28M-94.63M
Investing Cash Flow-455.95M-278.07M-113.36M-67.43M181.46M
Financing Cash Flow201.09M142.06M-174.44M100.38M-113.66M

Brookdale Senior Living Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price15.12
Price Trends
50DMA
13.00
Positive
100DMA
11.32
Positive
200DMA
9.32
Positive
Market Momentum
MACD
0.70
Positive
RSI
54.17
Neutral
STOCH
30.34
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BKD, the sentiment is Neutral. The current price of 15.12 is below the 20-day moving average (MA) of 15.59, above the 50-day MA of 13.00, and above the 200-day MA of 9.32, indicating a neutral trend. The MACD of 0.70 indicates Positive momentum. The RSI at 54.17 is Neutral, neither overbought nor oversold. The STOCH value of 30.34 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for BKD.

Brookdale Senior Living Risk Analysis

Brookdale Senior Living disclosed 37 risk factors in its most recent earnings report. Brookdale Senior Living reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Brookdale Senior Living Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
$1.94B20.648.58%18.77%6.88%
74
Outperform
$2.44B24.299.94%1.80%23.74%-18.99%
73
Outperform
$1.11B43.7410.87%29.89%10.33%
62
Neutral
$963.99M105.001.29%68.17%-85.42%
58
Neutral
$3.65B-13.55-214.33%3.93%-42.22%
52
Neutral
$1.47B20.0315.48%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BKD
Brookdale Senior Living
15.12
9.30
159.79%
ADUS
Addus Homecare
107.60
11.92
12.46%
NHC
National Healthcare
160.33
69.36
76.24%
ASTH
Astrana Health
19.95
-15.15
-43.16%
PNTG
Pennant Group
33.09
7.59
29.76%
AVAH
Aveanna Healthcare Holdings
7.21
2.99
70.85%

Brookdale Senior Living Corporate Events

Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
Brookdale Senior Living Reports Strong 2025 Results, Refinances Debt
Positive
Feb 18, 2026

Brookdale Senior Living reported its fourth-quarter and full-year 2025 results on February 18, 2026, showing a 5.7% increase in full-year consolidated RevPAR and a 310-basis-point improvement in fourth-quarter weighted average occupancy versus a year earlier, driven by strong move-in volume. Despite a 2025 net loss of $263 million, Adjusted EBITDA reached $458 million, above guidance, while the company reduced facility and administrative costs, lowered lease payments, and refinanced roughly $550 million of 2026–2027 mortgage debt, signaling operational momentum and a stronger capital structure that may support further growth in 2026.

The most recent analyst rating on (BKD) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on Brookdale Senior Living stock, see the BKD Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Brookdale Senior Living Issues Upbeat 2025 Preliminary Outlook
Positive
Jan 28, 2026

On January 28, 2026, Brookdale Senior Living announced preliminary 2025 results showing expected revenue of about $3.2 billion, up from $3.1 billion in 2024, and RevPAR growth of roughly 5.7%, while projecting a wider net loss of about $263 million due in part to roughly $71 million of non-cash impairment charges tied primarily to planned asset dispositions. Adjusted EBITDA for 2025 is expected to reach about $458 million, a 19% year-on-year increase and above prior guidance, though adjusted free cash flow will come in below the previously indicated range because of working capital changes, underscoring improving operating performance but continued bottom-line pressure as the company reshapes its portfolio. For 2026, Brookdale introduced guidance calling for 8%–9% RevPAR growth and adjusted EBITDA of $502 million to $516 million, reflecting the accretive impact of completed and announced dispositions, lease terminations and higher resident rate increases, and signaling management’s confidence in sustaining mid-teens adjusted EBITDA growth and gradual deleveraging in the coming years.

The most recent analyst rating on (BKD) stock is a Buy with a $13.00 price target. To see the full list of analyst forecasts on Brookdale Senior Living stock, see the BKD Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Brookdale Senior Living Reports Strong Occupancy Momentum Into 2026
Positive
Jan 12, 2026

On January 12, 2026, Brookdale Senior Living reported that its consolidated weighted average occupancy reached 82.5% in the fourth quarter of 2025, a 70-basis-point increase over the third quarter and a 310-basis-point gain year-on-year, underscoring a sustained recovery in utilization across its senior housing portfolio. December 2025 performance was particularly strong, with consolidated weighted average occupancy of 82.4% up 310 basis points from a year earlier and month-end occupancy rising 30 basis points sequentially, driven by unusually robust move-in and move-out activity for a typically weaker month, suggesting solid momentum heading into 2026 and potentially strengthening Brookdale’s operating leverage and competitive position in the senior living market.

The most recent analyst rating on (BKD) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on Brookdale Senior Living stock, see the BKD Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 20, 2026